IL18 and COVID-19: IL-18 is a proinflammatory cytokine released downstream of the activation of innate immune pathways, resulting in the formation of inflammasomes; it has already been correlated with a poor COVID-19 prognosis, since increased IL-18 levels have been found in patients with severe disease [21,22].